Catalog No.:  L-7118
MW: 454.58
CAS: 779333-56-1

Description:  Thio-ccPA is a stabilized analogue of carbacyclic phosphatidic acid (ccPA). It inhibits the lysoPLD activity of Autotaxin (ATX) and acts as an LPA1/3 receptor antagonist. Thio-ccPA decreases the viability of B16F10, A375, and MeWo melanoma cell lines. Addition of endogenous LPA did not reverse the effects of Thio-ccPA in B16F10 cells. Thio-ccPA decreased the number of pulmonary and non-pulmonary metastases in a B16F10 metastatic melanoma mouse model.


    -20 °C

Featured in Publications:

1) Xu, Y., G. Jiang, et al. (2006). "Phosphonothioate and Fluoromethylene Phosphonate Analogues of Cyclic Phosphatidic Acid: Novel Antagonists of Lysophosphatidic Acid Receptors." Journal of Medicinal Chemistry 49(17): 5309.
2) Altman, M. K., V. Gopal, et al. (2010). "Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid." Mol Cancer 9: 140.

Options/Sizes Pricing
L-7118-0.5mg $ 100.00
L-7118-1mg $ 173.00
Additional Information:
Tech Data Sheet - TDS_L-7118_v1

Add a specific quantity to your cart    *  

Back to the webstore startpage      Back to the product overview      Your Shopping Cart      Terms of Service

assay and reagents for drug discovery in lipid signaling pathways